Cyclododecene, 5,6,9,10-tetrabromo-, (1E,5S,6S,9R,10S)-rel- (853029-79-5)

Identification
Name:	Cyclododecene, 5,6,9,10-tetrabromo-, (1E,5S,6S,9R,10S)-rel-
CAS:	853029-79-5
Molecular Formula:	C₁₂H₁₈Br₄
Molecular Structure:
Properties
Safety Data

Other Product

Cyclododecene, 5,6,9,10-tetrabromo-, (1E,5S,6S,9S,10S)-rel-
Cyclododecene, 5,6,9,10-tetrabromo-, (1Z,5S,6R,9R,10S)-rel-
Butanoic acid,esters,(2R,4S,4aS,5S,6S,9R,10S,- 12S,12aS)-tetradecahydro-2,9,10-trihydroxy- 6,10-dimethyl-1-methylene-4-(1-methylethyl)- 5,12-epoxybenzocyclodecen-6-yl ester,rel-(+)-
3-Pyridinecarboxylicacid,(3R,5S,5aS,6S,9R,9aS,10R)-6-(acetyloxy)-5-(benzoyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-10-ylester (9CI)
3-Furancarboxylic acid,(3R,5S,5aS,6S,9R,9aS,10R)-6-(acetyloxy)-10-(benzoyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-5-ylester
3-Furancarboxylic acid,(3R,5S,5aS,6S,9R,9aS,10R)-6-(acetyloxy)-5-(benzoyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-10-ylester
2-Propenoic acid,3-phenyl-,(3R,5S,5aS,6S,9R,9aS,10R)-6-(acetyloxy)-5-(benzoyloxy)octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-10-ylester, (2E)-
9-Anthracenepropanamine,9,10-dihydro-N,N,10-trimethyl-2-(trifluoromethyl)-, (9R,10S)-rel-
1,3a-Ethano-3aH-benz[e]indene-2,9-diol,6- bromododecahydro-5a,9-dimethyl-10-(1- methylethyl)-,(1R,2R,3aS,5aS,6S,9R,9aS,9bS,- 10S)-
4,11-Dioxa-3,12-disilatetradec-6-ene,3,3,12,12-tetraethyl-9-methyl-10-[(1E,3E)-3-methyl-4-(trimethylstannyl)-1,3-butadienyl]-8-[(triethylsilyl)oxy]-, (6E,8R,9R,10S)-
2-Oxaspiro[4.5]dec-8-ene-1,4,7-trione,6-hydroxy-3-methylene-10-(1E)-1-propen-1-yl-, (5S,6S,10S)-
2-Propen-1-one,1-[(9R,10S)-9,10-dihydro-5,- 10-dihydroxy-9-methoxy-2,2,8,8-tetramethyl- 2H,8H-benzo[1,2-b:3,4-b']dipyran-6-yl]-3- (4-hydroxyphenyl)-,rel-(+)-
1-Oxa-6,8-diazaspiro[4.5]dec-6-ene-10-carboxylicacid, 7-amino-9-nonyl-, 7-[(aminoiminomethyl)amino]heptyl ester,(5R,9R,10S)-rel-(+)- (9CI)
Tricyclo[4.2.1.12,5]dec-3-en-9-ol, 1,9-diethyl-, (1R,2R,5S,6S,9R)-rel- (9CI)
(4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-10-[(2R,3R,4S,5R,6S)-3,4-dihydroxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy
2H-Oxecin-2-one,3,4,5,8,9,10-hexahydro-9-hydroxy-10-(1E,3Z,5Z)-1,3,5-undecatrienyl-,(6Z,9R,10S)- (9CI)
Butanoic acid,(2R,4S,4aS,5S,6S,10S,12S,12aS)-tetradecahydro-2-hydroxy-6,10-dimethyl-1-methylene-4-(1-methylethyl)-9-oxo-5,12-epoxybenzocyclodecen-6-ylester, rel-(+)- (9CI)
(2Z)-2-[(1R,2S,5S,6R,10S)-1,10-dihydroxy-2-[(1E,3E)-1-(hydroxymethyl)-9-methyl-5-methylidenedeca-1,3,8-trien-1-yl]-6-(3-hydroxypropyl)-10-methylspiro[4.5]dec-7-ylidene]propanal
Propanal,2-[(1R,2S,5S,6R,10S)-2-[(1E,3E)-1- [(acetyloxy)methyl]-9-methyl-5-methylene-1,- 3,8-decatrienyl]-1,10-dihydroxy-6-(3- hydroxypropyl)-10-methylspiro[4.5]dec-7- ylidene]-,(2Z)-
Formamide,N-[(1E,3R,4R,5R,9S,10S,11S)-11-[(1S,3S,4S,5S,7R,8S,9R,17S,19R)-4,17-dihydroxy-3,5,7-trimethoxy-4,8,14-trimethyl-11-oxo-10,23-dioxabicyclo[17.3.1]tricosa-12,14,20-trien-9-yl]-10-hydroxy-4-methoxy-3,5,9-trimethyl-6-oxo-1-dodecen-1-yl]-N-methyl-